Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a post hoc analysis based on a phase III trial.
Saved in:
| Title: | Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a post hoc analysis based on a phase III trial. |
|---|---|
| Authors: | Wang X; Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Li L; Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jan 06; Vol. 16, pp. 1685072. Date of Electronic Publication: 2026 Jan 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1685072 |
